01 1Aurobindo Pharma Limited
02 3Curia Italy S.r.l.
03 1Gilead Sciences, Inc.
04 1Guang’an Kingday Pharma & Chem Co., Ltd.
05 1Hospira Australia Pty Ltd
06 1Latina Pharma S.p.A.
07 1Sicor de Mexico S.A. de C.V
01 3AZTREONAM
02 1Aztreoanm
03 1Aztreonam
04 1Aztreonam Anhydrous
05 3aztreonam
01 1China
02 1India
03 1Mexico
04 5U.S.A
05 1Blank
NDC Package Code : 59651-859
Start Marketing Date : 2024-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 13538-001
Start Marketing Date : 2009-07-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (200kg/200kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 13538-008
Start Marketing Date : 2020-10-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (200kg/200kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 13538-009
Start Marketing Date : 2020-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (200kg/200kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52952-001
Start Marketing Date : 2012-07-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 24525-0025
Start Marketing Date : 2015-12-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 54087-160
Start Marketing Date : 2012-01-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER, FOR SOLUTION (75mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 63592-0180
Start Marketing Date : 2017-11-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61126-710
Start Marketing Date : 2023-08-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Aztreonam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aztreonam, including repackagers and relabelers. The FDA regulates Aztreonam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aztreonam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aztreonam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Aztreonam supplier is an individual or a company that provides Aztreonam active pharmaceutical ingredient (API) or Aztreonam finished formulations upon request. The Aztreonam suppliers may include Aztreonam API manufacturers, exporters, distributors and traders.
click here to find a list of Aztreonam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Aztreonam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Aztreonam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Aztreonam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Aztreonam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Aztreonam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Aztreonam suppliers with NDC on PharmaCompass.
We have 6 companies offering Aztreonam
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
